Balancing expectations: An unmet need in the orphan disease arena
Hear from HealthTech Healx which raised $10m to accelerate drug discovery
First treatment approved for Huntington’s Disease in almost a decade.
FDA approves Teva’s Huntington’s Disease drug
Funding rare disease treatments in the UK – navigating the labyrinth